Branded Drug Makers Face Increasingly Aggressive Challenges By Generic Makers, Study Finds

Law360, New York (May 31, 2005, 12:00 AM EDT) -- Makers of branded drugs are increasingly turning to patent litigation to defend their blockbuster drugs, a new survey has found.

Patent litigation remains the most commonly used generic defense strategy among makers of branded drugs, with 71% of drug companies reporting legal disputes to defend their patents in the past three years, according to research from pharmaceutical business intelligence firm Cutting Edge Information.

“The pharmaceutical industry faces a significant threat from generics companies who challenge existing patents and erode branded product sales. While patent defense constitutes...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.